Source Search Page
cancernetwork.com > view
Trastuzumab-strf Gets FDA Approval in Overexpressing Breast and Gastric Cancers
20+ hour, 10+ min ago —...was conducted at 89 centers across China, the Philippines, Poland... ...BioPharma in our efforts to improve access for patients," said Chrys Kokino... ..., vice chairman and managing director, Intas Pharmaceuticals.... ...products Administration], the European Medicines Agency (...
cancernetwork.com > view
Advancing CLL Treatment: Latest Updates and Strategies
1+ day ago —...Immunotherapy Approaches in AML Cancer Network sat down with Dr.... ...with Elizabeth Shpall, MD.... ...Revumenib Receives FDA Priority Review in R/R KMT2Ar Acute Leukemia... ...with relapsed/refractory KMT2A-rearranged acute leukemia. 2 Commerce Drive...
cancernetwork.com > view
New Tocilizumab Workflow Is More Effective for CRS Related to CAR T, Bispecific Antibodies
4+ day ago —...Andrea Wagner, MSN, RN, OCN.... ...results presented at the 2024 Oncology Nursing Society (ONS) Congress... ...Andrea Wagner, MSN, RN, OCN, of Hackensack University Medical Center... ...While this policy aligns with Hackensack Meridian Health practices...
cancernetwork.com > view
Frontline Treatment for EGFR-Mutated Lung Cancer
4+ day ago —...Hasson Charles, MD, MPH, FACS, discusses advances in equitable lung... ...Non–Small-Cell Lung Cancer ONCOLOGY spoke with Eric Ko, MD, PhD,... ...key trials across the lung cancer space. 2 Commerce Drive Cranbury... ...Treatment Options Combine Neoadjuvant and Adjuvant Therapies Misako Nagasaka...
cancernetwork.com > view
Dostarlimab Earns FDA Priority Review in All Advanced Endometrial Cancers
5+ day ago —...The FDA has set a Prescription Drug User Fee Act date of August 23... ...Previously, the FDA approved dostarlimab/chemotherapy for those with... ...Matthew Powell, MD, the Ira C. and Judith Gall Distinguished Professor... ...Mayadev, MD, on Pembrolizumab/CRT FDA Approval in Cervical Cancer...
cancernetwork.com > view
Patient Case 1: A 62-Year-Old Female with NSCLC
5+ day ago —...A 62-Year-Old Female with NSCLC Sandip Patel, MD, presents a case... ...62-year-old female patient with a PD-L1 expression of 60%, an EGFR...
cancernetwork.com > view
Systemic Treatment Options for Non-Small Cell Lung Cancer
5+ day ago —...Systemic Treatment Options for Non-Small Cell Lung Cancer Christine Bestvina... ...with NSCLC, bone and liver metastases, and an EGFR exon 20 insertion...
cancernetwork.com > view
Addressing the Growing Colorectal Cancer Incidence in Younger Populations
5+ day ago —...Charak, a board-certified colorectal surgeon at Palisades Medical... ...According to a news release from The American College of Surgeons... ...Surgeons Talk Key Treatment and Institutional Advances Across Oncology... ...Jun Gong, MD, and Daneng Li, MD, spoke about trials they feel can...
cancernetwork.com > view
Advice for Clinicians Administering Bispecifics to Patients With R/R MM
1+ week ago —...Drs Costello and Pianko close their discussion by sharing advice... ...an end point in trials leading to accelerated approvals by the FDA... ...patients with pretreated relapsed/refractory multiple myeloma. 2 Commerce Drive... ...vicleucel for relapsed/refractory multiple myeloma in the European Union...
cancernetwork.com > view
7-Gene Predictive Biosignature Helps Predict Ipsilateral Breast Cancer Recurrence
1+ week ago —...Patients with breast cancer who have a high-risk clinicopathology... ...but a low 10-year risk of ipsilateral breast recurrence (IBR) risk... ...Julie Margenthaler, MD, FACS, professor of surgery, Washington University... ...School of Medicine, and a surgeon at Siteman Cancer Center, stated...